EY
Eun Yang Jefferies Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$17.9B
| $396.24 | $432 |
9%
upside
| Buy |
23 Sep ‘24
11 months ago |
|
|
JBIO
2
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $7.52 | $70 |
831%
upside
| Hold |
17 Jun ‘24
1 year ago |
|
3
Taysha Gene Therapies
TSHA
$884M
| $3.24 | $8 |
147%
upside
| Buy |
14 May ‘24
1 year ago |
|
4
Astria Therapeutics
ATXS
$422M
| $7.47 | $27 |
261%
upside
| Buy |
25 Mar ‘24
1 year ago |
|
5
Rallybio
RLYB
$25.1M
| $0.6000 | $1.50 |
150%
upside
| Hold |
7 Feb ‘24
1 year ago |
|
|
OKUR
6
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.6M
| $2.48 | $18 |
626%
upside
| Hold |
15 Dec ‘23
1 year ago |
|
7
BridgeBio Pharma
BBIO
$10.1B
| $52.95 | $33 |
38%
downside
| Hold |
18 Jul ‘23
2 years ago |
|
8
Biomea Fusion
BMEA
$110M
| $1.85 | $28 |
1,414%
upside
| Hold |
26 Jun ‘23
2 years ago |
|
9
Enliven Therapeutics
ELVN
$1.14B
| $19.20 | $27 |
41%
upside
| Buy |
29 Mar ‘23
2 years ago |
|
10
Genasys
GNSS
$94.8M
| $2.10 | $7 |
233%
upside
| Outperform |
10 Feb ‘23
2 years ago |
|
11
Prime Medicine
PRME
$693M
| $3.89 | $25 |
543%
upside
| Buy |
14 Nov ‘22
2 years ago |
|
|
NCNA
12
NuCana
NCNA
$6.22M
| $3.26 | $15,000 |
460,023%
upside
| Buy |
22 Sep ‘22
3 years ago |
|
13
Pyxis Oncology
PYXS
$116M
| $1.87 | $25 |
1,237%
upside
| Buy |
2 Nov ‘21
3 years ago |
|
|
CNTA
14
Centessa Pharmaceuticals
CNTA
$3.05B
| $22.73 | $35 |
54%
upside
| Buy |
22 Jun ‘21
4 years ago |
|